Wells Fargo’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769 | Sell |
699
-29,191
| -98% | -$32.1K | ﹤0.01% | 5874 |
|
|
2025
Q1 | $29.3K | Buy |
29,890
+941
| +3% | +$922 | ﹤0.01% | 5127 |
|
|
2024
Q4 | $45.2K | Buy |
28,949
+4,724
| +20% | +$7.37K | ﹤0.01% | 5027 |
|
|
2024
Q3 | $88.9K | Buy |
24,225
+2,183
| +10% | +$8.01K | ﹤0.01% | 4688 |
|
|
2024
Q2 | $73K | Buy |
22,042
+21,208
| +2,543% | +$70.2K | ﹤0.01% | 4758 |
|
|
2024
Q1 | $3.55K | Sell |
834
-1,697
| -67% | -$7.23K | ﹤0.01% | 5553 |
|
|
2023
Q4 | $4.56K | Buy |
2,531
+23
| +0.9% | +$41 | ﹤0.01% | 5529 |
|
|
2023
Q3 | $4.99K | Buy |
2,508
+38
| +2% | +$76 | ﹤0.01% | 5581 |
|
|
2023
Q2 | $6.32K | Buy |
2,470
+307
| +14% | +$786 | ﹤0.01% | 5729 |
|
|
2023
Q1 | $8.67K | Buy |
2,163
+2,003
| +1,252% | +$8.03K | ﹤0.01% | 5586 |
|
|
2022
Q4 | $214 | Buy |
160
+14
| +10% | +$19 | ﹤0.01% | 6273 |
|
|
2022
Q3 | $0 | Buy |
146
+76
| +109% | – | ﹤0.01% | 6872 |
|
|
2022
Q2 | $0 | Sell |
70
-5,245
| -99% | – | ﹤0.01% | 7015 |
|
|
2022
Q1 | $21K | Sell |
5,315
-6,099
| -53% | -$24.1K | ﹤0.01% | 5652 |
|
|
2021
Q4 | $125K | Buy |
+11,414
| New | +$125K | ﹤0.01% | 5127 |
|